While NR4A1-dependent N-NCMs are naturally abundant under steady-state conditions in WT hosts, the NOD2-dependent subset can be pharmacologically induced to enhance tumor immunity against a variety of metastases. The gene discussed is NR4A1; the disease is neoplasm.